Director of Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Kruger Kurt H, buys 4,000 shares worth $11,740
According to Qualigen Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:05 AM, company Director, Kruger Kurt H disclosed buying 4,000 shares at a cost of $2.94. At the time of this transaction (Dec 29), this trade was worth $11,740 in total. As of Dec 29, Kruger Kurt H now owns 10,000 shares in total worth about $30,800.0.
For the last few recent trades made by Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Director, Kruger Kurt H, we have the following information:
- SEC Form 4 filing: Nov 20: Bought 1,400 shares at the rate of $3.55 per share. Total worth of this trade was $4,969. Total number of shares owned as of Nov 20 were 1,400
- SEC Form 4 filing: Nov 23: Bought 4,600 shares at the rate of $3.46 per share. Total worth of this trade was $15,925. Total number of shares owned as of Nov 23 were 6,000
Posted by
George Daniels
on Wednesday December 30 2020, 10:04 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
